About TransCell Science
TransCell Science is a company based in New York (United States) founded in 2011 was acquired by BioIVT in March 2017. TransCell Science operates in a competitive market with competitors including Kiyatec, Cellply, Lucid Scientific, CytoTronics and DiscoverX, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TransCell Science
Detailed funding history for TransCell Science
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in TransCell Science
TransCell Science has secured backing from 1 investor. Prominent investors backing the company include BioIVT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of in vitro diagnostic products and assay services
|
Locked | Locked | Locked |
Investor details for TransCell Science
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TransCell Science
Investment portfolio details for TransCell Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TransCell Science
Detailed financials for TransCell Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Transcell Science Comparisons
Peer comparison for TransCell Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TransCell Science
TransCell Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kiyatec, Cellply, Lucid Scientific, CytoTronics and DiscoverX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| Locked | Locked | Locked |
Develops cell-based assays and provides services for drug discovery and development.
|
|
| Locked | Locked | Locked |
3D cell culture products are developed for drug discovery applications.
|
Detailed competitors of TransCell Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Transcell Science
Complete news archive for TransCell Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TransCell Science
TransCell Science was founded in 2011.
TransCell Science is headquartered in New York, United States. It is registered at New York, New York, United States.
TransCell Science is a provider of research and development services to industry and academia. It specializes in novel drug and biologics assays based on human primary cells grown from explant tissue. The company claims it to be more advantageous than cell lines, organ culture or animal models. It custom develops and manages complex projects for pharmaceutical, personal care companies, and leading academic and government institutions. The company got acquired by BioreclamationIVT on 9th March, 2017.
TransCell Science's top competitors include CytoTronics, Kiyatec and Remedy Plan.
TransCell Science has 1 investor. Key investors include BioIVT.